\n\n\n\n\t\t\n\t\t\tReVance Therapeutics\n\t\t\thttp://www.revance.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tReVance Therapeutics is a private pharmaceutical company devoted to creating the next generation of aesthetic and therapeutic dermatology products with pipeline programs in facial aesthetics,...More»
\n\t\t\tReVance Therapeutics is a private pharmaceutical company devoted to creating the next generation of aesthetic and therapeutic dermatology products with pipeline programs in facial aesthetics, hyperhidrosis, melanoma, and regulation of fat metabolism to enhance skin and body contour. Located in Mountain View, California, the Company\'s pharmaceutical development programs are focused on integrating patented, proprietary transdermal molecular delivery and innovative tissue remodeling agents for the treatment of dermatologic conditions.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tMountain View, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\ttherapeutics,\n\t\t\t\trevnace,\n\t\t\t\trevance,\n\t\t\t\tpharmaceuticals,\n\t\t\t\thyperhidrosis,\n\t\t\t\taesthetics,\n\t\t\t\tmeatabolism,\n\t\t\t\tfat\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series C - $51.2M (05/12/2008)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tBiotechnology Development Fund,\n\t\t\t\t\t\n\t\tEssex Woodlands Health Ventures,\n\t\t\t\t\t\n\t\tKBL Healthcare Ventures,\n\t\t\t\t\t\n\t\tNiagra Gorge Venture Partners,\n\t\t\t\t\t\n\t\tPalo Alto Investors,\n\t\t\t\t\t\n\t\tShepherd Ventures,\n\t\t\t\t\t\n\t\tTechnology Partners,\n\t\t\t\t\t\n\t\tVivo Ventures,\n\t\t\t\t\t\n\t\tMedicis Pharmaceutical\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tNereus Pharmaceuticals,\n\t\t\t\t\tCytokinetics,\n\t\t\t\t\tDirect Therapeutics,\n\t\t\t\t\tPoniard Pharmaceuticals,\n\t\t\t\t\tPearl Therapeutics,\n\t\t\t\t\tBioMarker Pharmaceuticals,\n\t\t\t\t\tHyperion Therapeutics,\n\t\t\t\t\tPresidio Pharmaceuticals,\n\t\t\t\t\tPortola Pharmaceuticals\n\t\t\t\t
\n\t\t\tRecent News
\n\t\t\t\t\n\t\t\t\t\tJan 4, 2010\n\t\t\t\t\tRevance Confirms $25M Fundraising\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tDec 28, 2009\n\t\t\t\t\tReVance Therapeutics Nabs $25.62\n\t\t\t\t
\n\t\t\t